Farzana Rahiman

1. Radiotherapy plays an essential role in cancer therapy as it is used in at least two-thirds of all treatment regimens (Chen and Kuo 2017). Globally, approximately 50% of cancer patients receive ...

The rising prevalence of chronic burn wounds in South Africa places a significant burden on healthcare, driving the search for cost-effective, alternative treatments. Despite their long history of traditional use for skin ailments, the specific wound healing mechanisms of South African species Galenia africana L. and Tulbaghia violacea Harv. remain scientifically unvalidated, representing a critical knowledge gap and a novel area of inquiry. This study sought to evaluate the physiological and cellular effects of these plant extracts, specifically investigating their influence on keratinocyte function and oxidative stress. Initial analysis of crude ethanolic extracts confirmed the presence of key phenolic compounds like ferulic acid and rutin in both plants, with G. africana exhibiting a stronger overall radical-scavenging activity. In vitro assays were performed on the human keratinocyte (HaCaT) cell line. Both G. africana and T. violacea extracts significantly enhanced cell viability (at 40–80 μg/mL) and demonstrably reduced intracellular reactive oxygen species (ROS) levels, indicating a protective antioxidant effect. Critically, in the scratch wound assay, both extracts significantly accelerated cell migration and wound closure, achieving 76% (G. africana) and 88% (T. violacea) closure within 24 h. These findings suggest that G. africana and T. violacea extracts act to support keratinocyte proliferation and migration while simultaneously mitigating oxidative cellular damage. This work provides an important mechanistic basis supporting the traditional use of these specific, regionally important plants and highlights their high therapeutic potential as novel, cost-effective agents to accelerate skin repair and recovery.

Background: Medicinal plants are widely used across the globe as complementary and alternative therapies for managing various health conditions. The use of medicinal plants is a fundamental component of the African traditional healthcare system and most diverse therapeutic practices. Africa harbors a variety of plant species, many of which are estimated to be endemic, making it a rich source of medicinal plants with potential relevance to human health. Aim of the study: The study aimed to review and highlight the information in the literature related to the antimicrobial activity, wound-healing activity, and melanogenesis inhibition of African medicinal plants. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines, a literature search was conducted on ScienceDirect, Google Scholar, Medline Ebscohost, and PubMed, which were searched for articles published between 2018 and 2024. Due to high heterogeneity and variability in study designs, data were synthesized using a narrative approach. Result: A total of 37 studies were included. Emilia coccinea, Entada africana, Trichilia dregeana, Physalis angulata, and Prunus africana demonstrated strong wound-healing activity (100%) at concentrations between 5 and 10%. For melanogenesis inhibition, Ormocarpum trichocarpum (IC₅₀ = 2.95 µg/mL), Limonium cercinense (IC₅₀ = 3 µg/mL), and L. boitardii (IC₅₀ = 5 µg/mL) showed the most potent effects. The strongest antimicrobial effects were reported for Harpagophytum procumbens (MIC = 10 µg/mL) against Staphylococcus aureus and S. epidermidis and Pistacia atlantica (MIC = 78.1 µg/mL) against Listeria monocytogenes and Candida albicans (MIC = 39 µg/mL). Conclusions: This study highlights the broad therapeutic potential of African medicinal plant extracts in addressing various health conditions, including skin infections, wound management, and skin pigmentation. While several extracts demonstrated strong bioactivity, inconsistent reporting of statistical data limited quantitative synthesis. Future studies should adopt standardized methodologies and report complete statistical outcomes to enable robust meta-analyses and support clinical translation.

Microbial contamination of chronic wounds complicates their treatment. Traditional knowledge systems and the diversity of indigenous medicinal plants create a haven for traditional medicine practices in South Africa (SA). This systematic review aims to present a comprehensive ethnobotanical report of traditional medicines used in the documented empirical wound healing studies in SA. Google Scholar, PubMed, Medline EBSCOhost, Science Direct, and Scopus were sourced using the keywords/terminologies “South Africa”, “medicinal plants”, “traditional medicine” “indigenous”, “skin”, “wound”, “ethnobotany”, “survey”, “interview”, and “treatment” in different combinations. Relevant and unpublished records were retrieved from the Global Electronic Thesis Database. The searching process identified 32,419 records, of which 4005 studies were screened. Following the removal of 1795 duplicates, the remaining 2210 sources were screened by title and abstract, and 133 full-text reports were accessed and evaluated. Plants traditionally used for wound-healing purposes comprised 222 species belonging to 71 families, namely Asteraceae (predominantly the Helichrysum species), Asphodelaceae, Fabaceae, Solanaceae, and Euphorbiaceae. Plant organs used for medicinal remedies included leaves, roots, and bark prepared as poultices, infusions, decoctions, gel/ointments/lotions, and pastes. This review provides a valuable reference for future phytochemical and pharmacological studies and highlights the need for further ethnobotanical research to treat wounds in SA.

Following population declines of the African savanna elephant (Loxodonta africana) across the African continent, the establishment of primary cell lines of endangered wildlife species is paramount for the preservation of their genetic resources. In addition, it allows molecular and functional studies on the cancer suppression mechanisms of elephants, which have previously been linked to a redundancy of tumor suppressor gene TP53. This methodology describes the establishment of primary elephant dermal fibroblast (EDF) cell lines from skin punch biopsy samples (diameter: ±4 mm) of African savanna elephants (n = 4, 14–35 years). The applied tissue collection technique is minimally invasive and paves the way for future remote biopsy darting. On average, the first explant outgrowth was observed after 15.75 ± 6.30 days. The average doubling time (Td) was 93.02 ± 16.94 h and 52.39 ± 0.46 h at passage 1 and 4, respectively. Metaphase spreads confirmed the diploid number of 56 chromosomes. The successful establishment of EDF cell lines allows for future elephant cell characterization studies and for research on the cancer resistance mechanisms of elephants, which can be harnessed for human cancer prevention and treatment and contributes to the conservation of their genetic material.

Many people in developing countries rely primarily on medicinal plants as their main source of healthcare, particularly for the treatment of skin infections. Despite the widespread use of medicinal plants, there is a lack of literature describing the relevance and risks of exposure of the phytochemicals present. Galenia africana has been used traditionally in the form of pastes, decoctions, and lotions to treat wounds and other skin-related ailments. This is a report on the phytochemical composition of G. africana and a review on the pharmacological importance and relevance of these phytochemicals. The major groups of phytochemicals identified in G. africana extracts were aliphatics, aliphatic triterpenoids, fatty acids, flavonoids, and phenolic and tocopherol compounds. These have been found to exhibit medicinal properties, thus highlighting the need to assess the safety of G. africana for topical application. The information related to the safety of the various compounds could indicate the potential risks related to accidental intake of the extract upon topical product applications. This report concludes that the quantities of the phytochemicals present in G. africana should not cause undue risk to human health, which provides comfort to pursue future work on using and developing G. africana as a therapeutic agent.

In sub-Saharan Africa, the use of skin-lightening products (SLPs) for cosmetic purposes has become common practice among women with dark skin tones. Despite the associated risks, the practice is still significantly increasing in Africa. The objective of this study was to determine the knowledge, perceptions and practice toward skin lightening among young adults. A cross-sectional survey among health science students at a tertiary institution in the Western Cape of South Africa was conducted. A total of 401 participants were included in the sample. There was a low prevalence (12%) of skin-lightening practice among students, which could possibly be a result of students being aware of the associated side effects. Participants believed that family and friends are most likely to influence this behavior (48%) and perceived that individuals who practice skin lightening do so because this provides a more fashionable look (76%). Men and women were found to be equally likely to use SLPs, and those residing in urban settings are 10 times more likely to engage in the practice compared with rural dwellers. This study contributes valuable information on the phenomenon of skin lightening among a diverse group of young adults. The results highlight the influential role social media platforms and family members play in motivating use of SLPs. Furthermore, the equal likelihood of use among both sexes suggests that the practice is growing among males.

Malignant melanoma is the major cause of skin cancer-related deaths. Surgery in combination with radiotherapy, immunotherapy or chemotherapy is used to eradicate cancer cells, however, this treatment option is limited by the tolerance of the surrounding healthy tissue. The extracts from Galenia africana have been shown to possess anti-cancer flavonoid compounds and can be a safer and cost-effective alternative treatment. The study aimed to compare the anti-proliferative effects of G. africana on human skin cells (HaCaT) and human malignant melanoma cells (A375). The cells were exposed to various concentrations of the G. africana extract at different times. In vitro assays were employed to determine cell viability and cytotoxicity. Hoechst 33342 staining was performed to observe the nuclear changes, including apoptosis. G. africana significantly reduced the cell viability of the A375 cells in a dose and time-dependent manner, while having no effect on the HaCaT cells. The A375 cells displayed nuclear condensation, brightly stained nuclei and nuclear fragmentation indicative of apoptosis. This suggests a clinical rationale for the use of G. africana as a potential anti-melanoma agent offering efficacy and low toxicity. This study provides new insights for future work on investigating the utilization of G. africana in malignant melanoma treatment.